[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f5HxLqInL5v53UeA0U5toIzQi9ow7ulLEYNI5FiFfRDA":3,"$fHFbAszoj1A6Kb-EKhaC78Hz2ax78TiW07UhTZwNFl6o":59},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},5847,"aaragon-pharma-gmbh","Aaragon Pharma s.r.o.",null,"CZE","ted-v3","https://ted.europa.eu/de/notice/-/detail/308503-2026","2026-06-11 08:07:52","2026-07-20 02:00:55",3,1,"2026-07-08T00:00:00.000Z",[18,38,49],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":33,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},480966,151181,"469114-2026","https://ted.europa.eu/de/notice/-/detail/469114-2026","can-standard","2025-08-01T00:00:00.000Z","LOT-0001","Nilotinib (ausgenommen als Dispersion in Apfelmus), ATC L01EA03","Aaragon Pharma s.r.o","090 11 757","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)","DAK-Gesundheit","DE","33600000","2026-07-07T22:00:00.000Z",{"award_id":39,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":42,"award_notice_type":23,"award_date":43,"publication_date":44,"lot_number":25,"contract_title":45,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":46,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},469254,144005,"413359-2026","https://ted.europa.eu/de/notice/-/detail/413359-2026","2025-03-01T00:00:00.000Z","2026-06-16T00:00:00.000Z","Pegfilgrastim, ATC L03AA13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)","DE-HH","2026-06-15T22:00:00.000Z",{"award_id":50,"tender_id":51,"source_name":10,"source_award_id":52,"source_url":11,"award_notice_type":23,"award_date":53,"publication_date":54,"lot_number":25,"contract_title":55,"winner_name":56,"winner_identifier":28,"winner_country":9,"value_eur":15,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":57,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":58,"tender_deadline_utc":8},368936,27158,"308503-2026","2024-05-01T00:00:00.000Z","2026-05-06T00:00:00.000Z","Megestrol, ATC L02AB01","Aaragon Pharma GmbH","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Megestrol, ATC L02AB01 für die Zeit 01.05.2024 - 30.04.2026","2026-05-05T22:00:00.000Z",{"company_slug":6,"years":60,"award_count":14,"top_buyers":61,"yearly_trend":64},5,[62],{"buyer_name":34,"buyer_key":63,"award_count":14,"total_value_eur":15,"share_count":15},"dak-gesundheit",[65],{"year":66,"award_count":14},2026]